[8-K] Nukkleus Inc. Warrants Reports Material Event

Rhea-AI Filing Summary

Howard Hughes Holdings Inc. (HHH) – Form 4 insider filing

On 25-Jun-2025 the company reported that non-employee director David Eun was granted 2,094 shares of HHH common stock on 20-Jun-2025. The award was issued at a price of $0.00 per share as restricted stock under the issuer’s 2020 Equity Incentive Plan. According to the footnote, the shares will vest on the earlier of the 2026 annual meeting of stockholders or 01-Jun-2026, providing a defined service-based vesting schedule.

After the grant, Eun’s direct beneficial ownership increases to 6,430 shares. No derivative securities, options, dispositions, or cash purchases were reported. The filing was submitted by a single reporting person and does not reference a Rule 10b5-1 trading plan.

This Form 4 reflects a routine director equity grant intended to align board incentives with shareholder interests. The document contains no information on company financial performance, operational developments, or additional insider activity beyond the disclosed award.

Insights

Financial Analyst

TL;DR: Routine director stock grant; minimal valuation impact.

The Form 4 shows David Eun receiving 2,094 restricted shares, taking his direct stake to 6,430 shares. The award is part of the standard 2020 Equity Incentive Plan, has no cash cost, and vests in 2026. No sales, options, or derivative activity were reported. As the transaction is compensation-related and modest in size, it is unlikely to materially influence Howard Hughes Holdings’ market valuation or signal insider sentiment shifts. Investors typically view such grants as neutral housekeeping disclosures that modestly increase insider ownership alignment.

false 0001787518 0001787518 2025-06-15 2025-06-15 0001787518 NUKK:CommonStock0.0001ParValuePerShareMember 2025-06-15 2025-06-15 0001787518 NUKK:WarrantsEachWarrantExercisableForOneShareOfCommonStockFor92.00PerShareMember 2025-06-15 2025-06-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or Section 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 15, 2025

NUKKLEUS INC.

(Exact name of registrant as specified in its charter)

Delaware		001-39341		38-3912845
(State or other jurisdiction of incorporation or organization)		(Commission File Number)		(IRS Employer Identification Number)

575 Fifth Avenue, 14th Floor

New York, New York 10017

(Address of principal executive offices)

212-791-4663

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.0001 par value per share		NUKK		The Nasdaq Stock Market LLC
Warrants, each warrant exercisable for one Share of Common Stock for $92.00 per share		NUKKW		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

Emerging growth company  ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Item 1.01. Entry into a Material Definitive Agreement.

On June 15, 2025, Nukkleus Inc. (the “Company”) entered into Amendment No. 3 to the Securities Purchase Agreement and Call Option dated December 15, 2024 (“Purchase Agreement”) between the Company, Star 26 Capital Inc., a Nevada corporation (“Star 26”), the shareholders of Star 26 and Menachem Shalom, the representative of such shareholders, as amended by Amendment No. 1, dated as of February 11, 2025 and Amendment No. 2 dated May 13, 2025  (“Amendment No. 3”). Pursuant to the terms of Amendment No. 3, the parties clarified that if the Company fails to make all payments by the agreed time or if the Purchase Agreement is terminated as a result of the Company failing to perform or observe the covenants or agreements of the Company or if the Company fails to maintain its listing on Nasdaq, Star 26 shall be entitled to a payment from the Company in the amount of $3,000,000.

The above description of Amendment No. 3 is qualified in their entirety by reference to Amendment No. 3, a copy of which is attached hereto as Exhibit 10.1. 

Item 9.01 Financial Statements and Exhibits

Exhibit No		Description
10.1		Amendment No. 3 to the Securities Purchase Agreement and Call Option between the Company, Star 26, the shareholders of Star 26 and Menachem Shalom, the representative of such shareholders, dated as of June 15, 2025 (Incorporated by reference to Exhibit 10.31 of the Form S-1 Registration Statement filed June 18, 2025)
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

1

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	NUKKLEUS INC.
Date: June 20, 2025	By:	/s/ Menachem Shalom
	Name:	Menachem Shalom
	Title:	Chief Executive Officer

2

FAQ

When did Howard Hughes (HHH) report the insider transaction?

The Form 4 was filed on 25-Jun-2025, covering a transaction dated 20-Jun-2025.

How many shares were granted to Director David Eun?

2,094 shares of common stock were granted.

What type of equity was issued to the director?

Restricted stock granted under the 2020 Equity Incentive Plan.

When will the granted shares vest?

On the earlier of the 2026 annual shareholders’ meeting or 01-Jun-2026.

What is David Eun’s total beneficial ownership after the grant?

6,430 shares of HHH common stock held directly.